Pricing
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Industries
Headquarters
Employees
Links
Full screen
Niels C. Riedemann
View all
7 people · 0 jobs
5 people · 0 jobs
4 people · 0 jobs
3 people · 0 jobs
HQ
1 position, 0 job posts
BioNTech
32 followers
Tango Therapeutics
3 followers
Cellares
4 followers
Sanofi
281 followers
Gilead Sciences
159 followers
Regeneron
130 followers
Illumina
79 followers
Agilent Technologies
81 followers
Lonza
68 followers
Verily Life Sciences
45 followers
Alexion Pharmaceuticals
44 followers
Explore companies